Ubrolexin intramammary suspension for lactating dairy cows
Ubrolexin intramammary suspension for lactating dairy cows
Authorised
- Cefalexin monohydrate
- KANAMYCIN MONOSULPHATE
Product identification
Medicine name:
Ubrolexin intramammary suspension for lactating dairy cows
Ubrolexin
Active substance:
- Cefalexin monohydrate
- KANAMYCIN MONOSULPHATE
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefalexin monohydrate210.36milligram(s)1.00Syringe
-
KANAMYCIN MONOSULPHATE120247.00international unit(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal10day
-
Milk5day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- Cardboard box with 20 single use intramammary syringes and 20 teat wipes (containing isopropanol 70%). Each 10 g syringe contains 12 ml intramammary suspension and consists of a barrel with plunger and sealed sterile tip,all made of low density polyethylene.
- Cardboard box with 10 single use intramammary syringes and 10 teat wipes (containing isopropanol 70%). Each 10 g syringe contains 12 ml intramammary suspension and consists of a barrel with plunger and sealed sterile tip,all made of low density polyethylene.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Univet Limited
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 401157.00.00
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0221/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?: